Search HLF
HERBALIFE LTD.
NYSE · CIK 1180262
Last close12.56
Daily change+0.28 (2.28%)
10 Years gain-60.66%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
HLF · STANDARD
SIC 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Fiscal year end 1231
Fundamental
45.1Momentum
60.6Acceleration
60.6Confidence
78.0Annual Revenue18
Quarterly Revenue78
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth6.4 / 25
Quality11.2 / 25
Capital Efficiency20.0 / 20
Balance Sheet5.2 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 2.1112 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Low interest coverage · HIGHInterest coverage is 2.7813x.
Key Metrics
Revenue Growth TTM3.38%OK
Revenue CAGR 3Y-1.08%OK
Gross Margin77.81%OK
Operating Margin10.14%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC29.69%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.25%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $5.04B | $3.92B | $481.00M | $333.30M | $252.90M | 77.87% | 9.55% | 5.02% | 36.74% | 103.6M |
| 2025 FY Dec 31, 2024 | $4.99B | $3.89B | $385.90M | $285.40M | $163.40M | 77.88% | 7.73% | 3.27% | 25.46% | 101.6M |
| 2025 FY Dec 31, 2023 | $5.06B | $3.87B | $356.40M | $357.50M | $222.50M | 76.47% | 7.04% | 4.4% | 27.06% | 100.2M |
| 2024 FY Dec 31, 2022 | $5.20B | $4.03B | $545.20M | $352.50M | $196.10M | 77.45% | 10.48% | 3.77% | 48.87% | 99.5M |
| 2023 FY Dec 31, 2021 | $5.80B | $4.56B | $734.10M | $460.30M | $308.90M | 78.64% | 12.65% | 5.32% | 90.3% | 108.3M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $5.18B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-335172, 0001193125-25-267001 |
| Revenue Growth TTM | 3.38% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-335172, 0001193125-25-267001 |
| Revenue CAGR 3Y | -1.08% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-057113 |
| Revenue CAGR 5Y | -1.89% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-057113 |
| Gross Profit CAGR 3Y | -0.9% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-057113 |
| Operating Income Growth | 30.56% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001193125-26-335172, 0001193125-25-267001 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 77.81% | Gross Profit / Revenue | OK | 0001193125-26-335172, 0001193125-25-267001 |
| Operating Margin | 10.14% | Operating Income / Revenue | OK | 0001193125-26-335172, 0001193125-25-267001 |
| ROIC | 29.69% | NOPAT / Average Invested Capital | OK | 0001193125-26-335172, 0001193125-25-267001 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-335172 |
| Interest Coverage | 2.78x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.2x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.18x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-335172 |